Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.75 USD | +15.38% | +6.66% | +19.67% |
Financials (USD)
Sales 2024 * | 5.83M | Sales 2025 * | - | Capitalization | 382M |
---|---|---|---|---|---|
Net income 2024 * | -100M | Net income 2025 * | -73M | EV / Sales 2024 * | 19.6 x |
Net cash position 2024 * | 267M | Net cash position 2025 * | 377M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.08
x | P/E ratio 2025 * |
-3.54
x | Employees | 38 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.27% |
Latest transcript on Cartesian Therapeutics, Inc.
1 day | +15.38% | ||
1 week | +6.66% | ||
Current month | +12.14% | ||
1 month | +27.64% | ||
3 months | +13.03% | ||
6 months | -22.90% | ||
Current year | +19.67% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 24.75 | +15.38% | 164,501 |
24-05-13 | 21.45 | +1.32% | 25,200 |
24-05-10 | 21.17 | -3.16% | 54,832 |
24-05-09 | 21.86 | -5.98% | 44,221 |
24-05-08 | 23.25 | +0.19% | 41,193 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.67% | 382M | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- RNAC Stock